← Back to headlines
Organon and Henlius Launch Prolia and Xgeva Biosimilars in Canada
Organon and Henlius have launched biosimilar versions of Prolia and Xgeva in Canada, expanding treatment options for patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
